borgati4, nearly impossible to be objective when 'our' money in an equity. I respectfully disagree with you. The price is up because of the Webush/fly on the wall news today. It is possible big $$ believes Webush has what is called - the black edge - information others are not aware of . . . .. GLTA
true, watching the price bounce 5.18_5.17_5.19_5.18 ......cost me. penny wise, pound foolish.
bot Acad at $4, sold at $8 (duh) Chtp has $15-$20 potential long term. Derisked invst.
I placed the order at 11:22am, 1k @ 5.17...chtp was 5.18 .....logged off, clicked on "real time" and
THERE IT IS CHTP $5.35 !!, of course my order did not fill .......bot 500 @5.45 Zzzzzzz
3rd Q ending 9/30/13 - 33%, 4th Q ending 12/31/13 - 52% ....18 New Positions.
Retail investors do not have the resources of institutions. They can research the risks and uncertainties of biotech stocks with more accuracy than smaller investors. New #'s are bullish.
I have the nasdaq site saved , with real time quotes as the go to. The left side column has all the usual suspects; short int., institute holdings, after market quotes, sec, etc., and Stock Consultant (techs). This is a small sample of their technicals for today. Not a "trader" per se', but I respect tech. analysis.
Trade Quality- upside 100%, Excellent
. . .. . . . . . - downside 90%, Excellent
3 day chart alert- average neutral accumulation/distribution, stalemate between bulls and bears. ______________________________
Another week or 2 of trading sideways ? (unless kruschev starts shooting)
finally the bios are turning RED. Chtp is not alone - fspm, xoma, ecyt, drtx, ...whatever. I own Ambi for one reason, they are going to announce the start of enrollment of ph III this Q. Then I sell.
SAN DIEGO, March 6, 2014 /PRNewswire/ -- Ambit Biosciences (AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced it will report fourth quarter and full-year 2013 operational results after closing of the NASDAQ Global Market on Thursday, March 20, 2014
They are giving 2 week notice. Ok Chtp, give us the partnership news, not the ER/CC news.
mrd171742 - Chtp has NOT announced their ER date. The brokerage firms estimate.
Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.07. The reported EPS for the same quarter last year was $-0.03.
I'll stand by my guess, minimum 7 day notice. which now means cc next tue 3/11 at the earliest.
We ALL would like to see partnership announcement, the longer we wait for the boring ER , the better off we are ........am optimistic talks are ongoing. GLTU
you missed 20 posts saying partnership, 20 posts saying buyout, and 1 smartazz (ha) saying no partnership, no buyout, 15M shares@5 because all the talks fell through.
-bump- a buyout (50%premium=$9) could never compensate for the long term price appreciation. Acad, 5 to 8 to 16 to $30 in 1 yr.. Chtp 5 to 8 to $15 in 1 year is possible, fibromyalgia $1B in revenue. I want $12 BO..
No hurray to buy. Downtrend is in , possibly all week. The cc with year-end earnings, wait for the company guidance going forward. 9 out of 10 bio's SELL OFF after earnings. Chtp, $4.50-$5 a share after cc.
the importance of this post is important : ) - "in the UK they are looking at approval for fibromyalgia"
...... in the U.S. fibromyalgia affects an estimated 5.8 million Americans" -off label revenue, big. !
FD - fair disclosure, No nasdaq/nyse company would ever be allowed to announce the buyout of another company during a conference call. No way, not allowed. Material information of that kind would require a P.R., most likely pre-market or after hours.
--- joecool...has always been topline with regards to CHTP (posts)
We have our answer. No partner, no buyout. The "market" put 2 and 2 together, it wasn't the SA article alone, the new job openings are the red flag. Chtp going it alone. The dilution will cause temporary dementia, we'll have to get over it.
"attract, develop .....train .....high performance sales team" -
the speculation (mandatory) - 4 regional sales managers, east coast-west coast-Midwest and Canada. Each manager hires a sales force (25?) for their region. That's it, 120 employees.
Our partner in Japan provides the goods, Chtp distributes North America, with EMA authorization Europe too.
- or if it includes prior short positions being closed. If it's the latter, it would certainly explain why we went down today. . ." - z, I don't understand. "Short positions being closed", meaning shorts are buying back the shares they previously sold, no ? Wouldn't that reflect an increase in share price, covering.
Short interest is most definitely a consensus of the direction the stock is heading. Always important to keep an eye on. We're not out of the woods with this position. No partner no buyout (lol) , here it comes- delusion. - But then this board is 75% entertainment, we can all be bagholders together at $6 to $7 a share till fall.
hey usingaliase - same here! sold xoma , bot 1 month ago, up 20% - now holding 2k shares of chtp. Not a "trader" per se, but I believe chtp is undervalued at $6. I don't really know short term outlook. $5.50 ? $6.50 ? Do I hear 8 ? glta
AMBI: Ambit Biosciences ________ DRTX: Durata Therapuetics
float: 9 Million ~~ OS 18M . . . . . . . . 8 Million ~~ OS 26M
short : 1% (lol) . .. . . .. . . . . . . . . . . .17%
cash : 78M . . . . .. . . . . . . . . 66M
Binary: Ambit scheduled to announce ph III enrollment in March. Low float could result in 30%+
. . . . .: Drtx scheduled for ADCOM meeting on March 31st. Low float/extreme upside potential
Ambit ~~~~~ $10.50 , Drtx ~~~~~~ $13.50
Good people here, some who made money, some who haven't..... ...yet : )
The FDA and Wall Street - 2 separate entities. The SEC oversees Nasdaq and the Dow. Trading halt on PFUFA date would not allow billion dollar hedge funds, banks, Instit, etc., to initiate a "bear raid" to take out stops (to buy low) AND to cover millions of short shares to realize profit before news.
CHTP absolutely received news from the FDA before 5pm. - With no news of any kind by 4pm, the after hours trading went downhill and really started to steamroll. Obviously the market consensus was bad news ahead.
On the nasdaq site the low was reached at 18:55pm, $3.50 (good news tue. and 250% profit in 1 day,$9 ?
IN ORDER TO STOP THE SELL OFF, CHTP released their p.r at 6:55pm (18:55) , within 1 minute we hit $4.99 a share, with an after hours high of $5.
As I have always believed the market is honest, efficient, transparent, level playing field for all investors large or small, with not a hint of corruption or insider trading info. , I will continue investing. LOL !!